Spyre Therapeutics Inc (SYRE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Sales | 198 | 168 | 174 | 625 | 1,362 |
| Gross Profit | 198 | 168 | 174 | 625 | 1,362 |
| Operating Expenses | 19,004 | 19,330 | 18,929 | 23,048 | 25,803 |
| Operating Income | -18,806 | -19,162 | -18,755 | -22,423 | -24,441 |
| Other Income | 348 | 404 | 312 | 109 | 5 |
| Pre-tax Income | -18,458 | -18,758 | -18,443 | -22,314 | -24,436 |
| Income Tax | -36 | 64 | -209 | 9 | N/A |
| Net Income Continuous | -18,422 | -18,822 | -18,234 | -22,323 | -24,436 |
| Net Income | $-18,422 | $-18,822 | $-18,234 | $-22,323 | $-24,436 |
| EPS Basic Total Ops | -4.89 | -4.02 | -4.84 | -6.75 | -9.25 |
| EPS Basic Continuous Ops | -4.89 | -3.98 | -4.84 | -6.79 | -9.26 |
| EPS Diluted Total Ops | -4.89 | -4.02 | -4.84 | -6.75 | -9.25 |
| EPS Diluted Continuous Ops | -4.89 | -3.98 | -4.84 | -6.79 | -9.26 |
| EBITDA(a) | $-18,258 | $-18,824 | $-18,405 | $-21,986 | $-23,929 |